atenolol has been researched along with c-peptide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berglund, A; Elmfeldt, D; Fagerberg, B; Holme, E; Wilhelmsen, L | 1 |
| Fyhrquist, F; Groop, L; Groop, PH; Kala, R; Tolppanen, EM; Tötterman, K | 1 |
| Arakawa, K; Kajiyama, G; Kusukawa, R; Mashiba, H; Nonaka, K; Sasaki, J; Shichiri, M; Sunaga, T; Tanaka, N | 1 |
| Aviran Barak, N | 1 |
3 trial(s) available for atenolol and c-peptide
| Article | Year |
|---|---|
Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
Topics: Aged; Atenolol; Blood Pressure; C-Peptide; Delayed-Action Preparations; Double-Blind Method; Glucose; Glycated Hemoglobin; Heart Rate; Humans; Hypertension; Insulin; Lipoproteins; Metoprolol; Middle Aged | 1990 |
Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; C-Peptide; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Humans; Hypertension; Insulin; Islets of Langerhans; Male; Middle Aged; Propranolol; Random Allocation | 1984 |
Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Apolipoprotein A-II; Apolipoproteins; Atenolol; Blood Glucose; Blood Pressure; C-Peptide; Calcium Channel Blockers; Dihydropyridines; Heart Rate; Hemoglobins; Humans; Hypertension; Insulin; Lipoproteins; Middle Aged; Treatment Outcome | 1995 |
1 other study(ies) available for atenolol and c-peptide
| Article | Year |
|---|---|
[MERCAPTIZOL INDUCED HYPOGLYCEMIA - A CASE REPORT].
Topics: Adult; Atenolol; Autoantibodies; C-Peptide; Female; Humans; Hypoglycemia; Insulin Antibodies; Iodine; Sugars | 2022 |